Active10558331Private limited companyBristol

NGBPHARMA LIMITED

Significant control: Nour Goubaa (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Ngbpharma Limited sell?

Registered activity: Other human health activities (SIC 86900). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

NGBPHARMA LIMITED is an active private limited company (company number 10558331) incorporated on 11 January 2017, registered in Bristol. Its registered activity is other human health activities (SIC 86900). Latest micro accounts cover the period ending 30 April 2025, showing net assets of £43k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 43% on the prior period (£76k).

Peer position · net assets

By net assets it sits in the top quarter of 958 comparable companies in Bristol (median £1,952, upper quartile £18k).

02

Ownership and control

1 active
  • Mr Nour Goubaa
    Individual · since 11 January 2017
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
11 January 20179 yrs ago
Next accounts due
30 January 2027in 100 days
Confirmation statement due
25 January 2027in 95 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 86900
Other human health activities
Accounts type
Micro Entity
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 30 April 2025
Net assets
£43k
−43%vs Apr 2024
Cash at bank
Not reported
Turnover
Not disclosed
Employees
2
Not reported the period before
Net assets
£43k
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 April 2025£43k——£55k——2
30 April 2024£76k——£30k———
Current ratio1.77Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £42,896 at 30 April 2025
  • Net assets down 25% or more on the prior period-43.2% vs prior period
  • Current assets at least 1.5× creditors within one yearCurrent ratio 1.77
  • Incorporated five or more years agoIncorporated 11 January 2017

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 100 days
  2. Confirmation statement duein 95 days
  3. Accounts period endNet assets £43k · micro accounts
  4. Accounts period endNet assets £76k · micro accounts
  5. Incorporated
08

Similar companies in Bristol

Same activity (other human health activities), closest in incorporation date
09

Reminders for NGBPHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.